A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.

Eugenio Sangiorgi, Fiorella Gurrieri, Annamaria Milillo, Francesca La Carpia, Stefano Costanzi, Maurizio Martini, Luigi Maria Larocca, Gisella Vischini

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

7 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.'. Insieme formano una fingerprint unica.

Biochemistry, Genetics and Molecular Biology